Sai Life Sciences Q1 Results: Earnings Call Scheduled for August 7
Sai Life Sciences Limited has scheduled its Q1FY27 earnings call for August 7, 2026, at 4:00 PM IST. The event aims to discuss unaudited financial results for the quarter ended June 30, 2026, in compliance with SEBI Regulation 30. Managing Director Krishna Kanumuri and CFO Siva Chittor will lead the discussion, providing insights into the company's performance as a leading CRDMO.
*this image is generated using AI for illustrative purposes only.
Sai Life Sciences Limited will host an earnings conference call on Friday, August 7, 2026, at 4:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. The announcement, filed with the National Stock Exchange of India Limited and BSE Limited on July 30, 2026, provides investors with the schedule to access management commentary on the company’s performance in Q1FY27. This disclosure ensures timely transparency regarding the firm's operational and financial standing for the period.
The conference call is conducted pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The session will begin with a brief management discussion on earnings performance, followed by an interactive question-and-answer segment. Investors and analysts can participate via dial-in or through a pre-registration link provided in the exchange filing.
Conference Call Details
| Parameter | Details |
|---|---|
| Date | August 7, 2026 |
| Time | 4:00 PM – 5:00 PM (IST) |
| Dial-in Number | +91 22 6280 1107, +91 22 7115 8008 |
| International | USA: 18667462133, UK: 08081011573 |
Management Representation
Senior leadership from Sai Life Sciences Limited will address stakeholders during the call. The key participants include:
- Krishna Kanumuri, Managing Director & Chief Executive Officer
- Siva Chittor, Director and Chief Financial Officer
About Sai Life Sciences Limited
Sai Life Sciences is one of India's fastest-growing Contract Research, Development, and Manufacturing Organizations (CRDMO). Headquartered in Hyderabad, the company partners with innovator pharmaceutical and biotech firms to accelerate the discovery, development, and commercialization of new medicines. Its integrated solutions span medicinal chemistry, process development, clinical and commercial manufacturing, and advanced technology platforms.
Historical Stock Returns for Sai Life Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.03% | +5.20% | +5.42% | +58.92% | +58.22% | +72.04% |
How might Sai Life Sciences' Q1FY27 performance reflect broader trends in global pharmaceutical outsourcing and CRDMO demand?
What impact could the company's unaudited results have on its valuation relative to other Indian CRDMO peers in the coming quarter?
Will management provide updates on the pipeline of new client contracts or major milestones in clinical manufacturing during the call?
19
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
